| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026030 |
| Receipt No. | R000029915 |
| Official scientific title of the study | Effects of a Test Food for Improvement of Skin Moisturizing Function and Its Safety |
| Date of disclosure of the study information | 2017/02/20 |
| Last modified on | 2017/12/14 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Effects of a Test Food for Improvement of Skin Moisturizing Function and Its Safety | |
| Title of the study (Brief title) | Effects of a Test Food for Improvement of Skin Moisturizing Function and Its Safety | |
| Region |
|
|
| Condition | ||
| Condition | N/A(healthy adaults) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study aims to examine effects of a test food for improvement of skin moisturizing function and its safety for subjects by 8-week ingestion. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | [1]Transepidermal water loss (Screening, Week 0, Week 4, Week 8)
[2]Skin moisture content (Screening, Week 0, Week 4, Week 8) |
| Key secondary outcomes | *Secondary outcomes
[1]Visual evaluation (Screening, Week 0, Week 4, Week 8) *Other index [1]Anti-Aging QOL Common Questionnaire (Screening, Week 0, Week 4, Week 8) *Safety evaluation [1]Blood pressure, pulsation (Screening, Week 0, Week 4, Week 8) [2]Weight, body fat percentage, BMI (Screening, Week 0, Week 4, Week 8) [3]Hematologic test (Screening, Week 0, Week 8) [4]Blood biochemical test (Screening, Week 8) [5]Blood test (Screening, Week 0, Week 8) [6]Urine analysis (Screening, Week 0, Week 8) [7]Doctor's questions (Screening, Week 0, Week 4, Week 8) [8]Subject's diary(From the first day of ingestion of a test material to the last day of the test) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Oral ingestion of the test food (8 weeks) | |
| Interventions/Control_2 | Oral ingestion of the placebo food A (8 weeks) | |
| Interventions/Control_3 | Oral ingestion of the placebo food B (8 weeks) | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | [1]Japanese females aged 30-59 years.
[2]Individuals who are healthy and are not suffered from a chronic malady including skin disease. [3]Individuals who are anxious about skin dryness. [4]Individuals whose written informed consent has been obtained. [5]Individuals who can visit an inspection facility and be inspected in designated days. [6]Individuals judged appropriate for the study by the principal. |
|||
| Key exclusion criteria | [1]Individuals using medical products.
[2]Individuals who use a drug to treat a disease in the past 1 month. [3]Individuals with skin disease, such as atopic dermatitis. [4]Individuals who contract or have a history of serious hepatopathy, kidney damage, heart disease and blood disease. [5]Individuals who contract or have a history of serious endocrine disease. [6]Individuals whose systolic blood pressure is over 160mmHg or diastolic pressure is over 100mmHg. [7]Individuals whose BMI is over 30. [8]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [9]Individuals with serious anemia. [10]Individuals who are sensitive to a test producer other foods, and medical products. [11]Individuals who are or are possibly, or are lactating. [12]Individuals who are alcoholism or mental disorders. [13]Individuals who have a habit of smoking. [14]Individuals whose bowel habit is irregular. [15]Individuals whose life style will change during the test period. [16]Individuals with probable seasonal allergy, such as pollinosis, during the test period. [17]Individuals who will get sunburned during the test period (including winter sports like skiing and snowboarding). [18]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. [19] Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months. [20] Individuals who use cosmetics having a strong moisturizing effect or improving effect for wrinkle. [21]Individuals who had been conducted an operation on the test spot in the past 6months. [22]Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months. [23]Individuals who are or whose family is engaged in healthy or functional foods. [24]Individuals judged inappropriate for the study by the principal. |
|||
| Target sample size | 45 | |||
| Research contact person | |
| Name of lead principal investigator | Takahiro Ono |
| Organization | Medical Corporation Wakei-kai Medics Hongo Clinic |
| Division name | Director |
| Address | 2-2-6 Mukogaoka Bunkyo-ku Hongo Tokyo 113-0023, JAPAN |
| TEL | 03-6801-9761 |
| info@tes-h.co.jp | |
| Public contact | |
| Name of contact person | Ryoma Shimizu |
| Organization | TES Holdings Co., Ltd |
| Division name | Administrative Department of Clinical Trials |
| Address | 6F University of Tokyo Entrepreneur Plaza 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033, JAPAN |
| TEL | 03-6801-8480 |
| Homepage URL | |
| r.shimizu@tes-h.co.jp | |
| Sponsor | |
| Institute | TES Holdings Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | LG Household & Health Care Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Outside Japan |
| Nationality of Funding Organization | Korea |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029915 |